Wuhan Competitors

300871 Stock   11.01  0.60  5.17%   
Wuhan Hvsen Biotechnology competes with China State, Poly Real, China Vanke, China Merchants, and Huafa Industrial; as well as few others. The company operates under Biotechnology sector and is part of Health Care industry. Analyzing Wuhan Hvsen competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Wuhan Hvsen to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Wuhan Hvsen Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Wuhan Hvsen competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
7.2710.9814.69
Details
Intrinsic
Valuation
LowRealHigh
5.208.9112.62
Details
Naive
Forecast
LowNextHigh
7.0710.7914.50
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Wuhan Hvsen. Your research has to be compared to or analyzed against Wuhan Hvsen's peers to derive any actionable benefits. When done correctly, Wuhan Hvsen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Wuhan Hvsen Biotechnology.

Wuhan Hvsen Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Wuhan Hvsen and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Wuhan and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Wuhan Hvsen Biotechnology does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Wuhan Stock performing well and Wuhan Hvsen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Wuhan Hvsen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
601668  2.12  0.25  0.03 (0.30) 2.40 
 5.25 
 15.78 
600048  2.20  0.36  0.08 (2.46) 2.85 
 5.32 
 20.02 
000002  2.57  0.41  0.10  4.39  2.65 
 8.70 
 20.01 
001979  2.38  0.36  0.08  3.74  3.03 
 4.99 
 19.96 
600325  2.16  0.23  0.04 (3.15) 2.64 
 6.36 
 20.03 
601995  2.39  0.42  0.10  11.53  2.72 
 8.00 
 20.01 
600519  1.66  0.19  0.02 (0.37) 1.80 
 6.55 
 16.71 
600153  2.03  0.44  0.13 (2.12) 2.01 
 6.39 
 19.45 
300750  2.60  0.81  0.19 (0.94) 2.93 
 7.94 
 33.42 
600340  4.65  1.58  0.29  1.63  3.93 
 10.14 
 20.27 

Cross Equities Net Income Analysis

Compare Wuhan Hvsen Biotechnology and related stocks such as China State Construction, Poly Real Estate, and China Vanke Net Income Over Time
201020112012201320142015201620172018201920202021202220232024
6016682.4 B13.5 B15.7 B20.4 B22.6 B26.1 B29.9 B32.9 B38.2 B41.9 B44.9 B51.4 B51 B54.3 B28.6 B
600048406.8 M6.5 B8.4 B10.7 B12.2 B12.3 B12.4 B15.6 B18.9 B28 B28.9 B27.4 B18.3 B12.1 B13 B
000002309.4 M9.6 B12.6 B15.1 B15.7 B18.1 B21 B28.1 B33.8 B38.9 B41.5 B22.5 B22.6 B12.2 B14.6 B
0019794.9 B4.9 B4.9 B4.9 B4.9 B4.9 B9.6 B12.2 B15.2 B16 B12.3 B10.4 B4.3 B6.3 B8.1 B
60032556.3 M770.1 M545.8 M538.3 M646.7 M680.1 MB1.6 B2.3 B2.8 B2.9 B3.2 B2.6 B1.8 B1.3 B
6019952.8 B2.8 B2.8 B2.8 B2.8 B2.8 B2.8 B2.8 B3.5 B4.2 B7.2 B10.8 B7.6 B6.2 B6.6 B
600519251.1 M8.8 B13.3 B15.1 B15.3 B15.5 B16.7 B27.1 B35.2 B41.2 B46.7 B52.5 B62.7 B74.7 B78.5 B
600153103.3 M2.3 B2.2 B2.7 B2.5 B2.6 B2.9 B3.3 B4.7 B4.7 B4.5 B6.1 B6.3 B13.1 B13.8 B
300750BBBBBBBB3.4 B4.6 B5.6 B15.9 B30.7 B44.1 B46.3 B
60034021.6 M1.4 B1.8 B2.7 B3.5 B4.8 B6.5 B8.8 B11.7 B14.6 B3.7 B(39 B)1.6 B(6 B)(5.7 B)

Wuhan Hvsen Biotechnology and related stocks such as China State Construction, Poly Real Estate, and China Vanke Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Wuhan Hvsen Biotechnology financial statement analysis. It represents the amount of money remaining after all of Wuhan Hvsen Biotechnology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Wuhan Hvsen Competitive Analysis

The better you understand Wuhan Hvsen competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Wuhan Hvsen's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Wuhan Hvsen's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
300871 601668 600048 000002 001979 600325 601995 600519 600153 300750
 5.17 
 11.01 
Wuhan
 2.46 
 5.95 
China
 4.14 
 9.73 
Poly
 3.00 
 8.42 
China
 3.39 
 10.53 
China
 3.44 
 6.46 
Huafa
 4.01 
 34.68 
China
 2.39 
 1,508 
Kweichow
 3.58 
 9.42 
Xiamen
 3.41 
 259.10 
Contemporary
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Return On Asset
Book Value Per Share
Total Asset
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Wuhan Hvsen Competition Performance Charts

Five steps to successful analysis of Wuhan Hvsen Competition

Wuhan Hvsen's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Wuhan Hvsen Biotechnology in relation to its competition. Wuhan Hvsen's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Wuhan Hvsen in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Wuhan Hvsen's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Wuhan Hvsen Biotechnology, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Wuhan Hvsen position

In addition to having Wuhan Hvsen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Single Stock ETFs Thematic Idea Now

Single Stock ETFs
Single Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 99 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Wuhan Stock

Wuhan Hvsen financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Hvsen security.